ArticlePharmaceuticals (Basel, Switzerland)2022

Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs.

Gisele Barbosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.